Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | +1.41% | +2.86% | +111.76% |
05-13 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-08 | IMUNON, Inc. Appoints Stacy R. Lindborg as Chief Executive Officer, Effective May 13, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IMUNON, INC. | Bio Therapeutic Drugs | +1.41% | +2.86% | +111.76% | +6.67% | -95.36% | 13.35M |
- Stock Market
- Equities
- IMNN Stock
- Charts Imunon, Inc.
- Relative Strength Chart